Other pancytopenia
ICD-10 D61.818 is a billable code used to indicate a diagnosis of other pancytopenia.
Pancytopenia is a hematological condition characterized by the simultaneous reduction of red blood cells, white blood cells, and platelets. The code D61.818 specifically refers to cases of pancytopenia that do not fall under the more common categories such as aplastic anemia or hereditary conditions. Aplastic anemia, a significant cause of pancytopenia, results from bone marrow failure, leading to a decrease in hematopoietic stem cells. This can be acquired through various factors including autoimmune diseases, exposure to toxins, or viral infections. Other acquired anemias, such as those resulting from hypersplenism or malignancies, can also lead to pancytopenia. The diagnosis of other pancytopenia requires thorough investigation to identify underlying causes, which may include bone marrow biopsy, blood tests, and imaging studies. Clinicians must differentiate between primary bone marrow disorders and secondary causes to ensure appropriate management. Treatment may involve addressing the underlying cause, transfusions, or immunosuppressive therapy, depending on the etiology.
Detailed lab results, bone marrow biopsy reports, and treatment plans.
Diagnosis and management of patients presenting with unexplained anemia, leukopenia, and thrombocytopenia.
Ensure all relevant laboratory tests and clinical findings are documented to support the diagnosis.
Comprehensive cancer history, treatment regimens, and response to therapy.
Patients with malignancies presenting with cytopenias due to bone marrow infiltration.
Document any chemotherapy or radiation therapy that may contribute to bone marrow suppression.
Used to evaluate patients presenting with symptoms of anemia or cytopenia.
Document the reason for the CBC and any relevant clinical findings.
Hematologists should ensure that all relevant lab results are included in the patient's record.
Common causes include autoimmune disorders, hypersplenism, infections, and certain medications that affect bone marrow function.
